BiomX (PHGE) Short term Debt (2019 - 2026)
BiomX's (PHGE) quarterly Short term Debt came in at $210000.0 in Q2 2026, down 96.37% quarter-over-quarter from $5.8 million in Q4 2023.
Analysis
BiomX (PHGE) Short term Debt (2019 - 2026) Analysis & Trends
BiomX has disclosed Short term Debt across 6 years of filings, most recently posting $210000.0 for Q2 2026.
- In Q2 2026, Short term Debt changed N/A year-over-year to $210000.0; the TTM figure through Jun 2026 stood at $210000.0 (changed N/A YoY), while the FY2023 annual figure was $5.8 million, up 35.1% from the prior year.
- Short term Debt came in at $210000.0 for Q2 2026 at BiomX, down from $5.8 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $5.8 million in Q4 2023 to a low of $210000.0 in Q2 2026.
- Average Short term Debt over 3 years is $1.6 million, with a median of $687000.0 recorded in 2022.
- Year-over-year, Short term Debt surged 422.83% in 2022 and dropped 15.32% in 2023.
- Over 3 years, Short term Debt stood at $4.3 million in 2022, then soared by 35.1% to $5.8 million in 2023, then slumped by 96.37% to $210000.0 in 2026.
- Per Business Quant data, the three most recent Short term Debt figures were $210000.0 in Q2 2026, $5.8 million in Q4 2023, and $632000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BiomX | 1.55 Mn | 7.73 Mn | 97,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210,000.00 |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 632,000.00 |
| Jun 30, 2023 | 654,000.00 |
| Mar 31, 2023 | 669,000.00 |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 687,000.00 |
| Jun 30, 2022 | 708,000.00 |
| Mar 31, 2022 | 790,000.00 |
| Dec 31, 2021 | 819,000.00 |
| Sep 30, 2021 | 799,000.00 |
| Jun 30, 2021 | 791,000.00 |
| Mar 31, 2021 | 763,000.00 |
| Dec 31, 2020 | 863,000.00 |
| Sep 30, 2020 | 594,000.00 |
| Jun 30, 2020 | 369,000.00 |
| Mar 31, 2020 | 361,000.00 |
| Dec 31, 2019 | 375,000.00 |